Last reviewed · How we verify

NCT04646707

Effect of Erector Spinae (ESP) Block on Opioid Reduction and Enhanced Recovery After Posterior Cervical Spine Surgery

Recruiting now NA Last updated 30 January 2025
What this trial tests

NA trial testing Erector Spinae (ESP) Block with Lidocaine/Bupivacaine in Postoperative in 52 participants. Currently enrolling.

Timeline
17 February 2020
Primary endpoint
17 December 2025
30 December 2025

Quick facts

Lead sponsorUniversity Health Network, Toronto
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment52
Start date17 February 2020
Primary completion17 December 2025
Estimated completion30 December 2025
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University Health Network, Toronto

Who can join

Adults 18 to 80, any sex, with Postoperative or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients undergoing spine surgery frequently experience significant pain after surgery. This can limit patient activity and hinder rehabilitation. If inadequately treated, severe pain can result in emotional and psychological distress and ultimately impact long-term function, and increase the risk of developing pain that lasts longer than six months associated with depression, anxiety and disability. More specifically, Erector Spinae Plane (ESP) block is a recently described plane block designed to block the dorsal and ventral rami of the thoracic spinal nerves. It has shown to be an effective modality for postoperative pain management as a part of multimodal analgesia in spinal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Erector Spinae (ESP) Block with Lidocaine/Bupivacaine

Trials testing the same drug.

Other recruiting trials for Postoperative

Currently open trials in the same condition.

Other University Health Network, Toronto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04646707.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing